Date: 29-31 October 2024
Location: Barcelona, Spain

Event Website

Read more

Date: 22-25 October 2024
Location: Rome, Italy

Presenting:
Karthikeyan Devaraju, Senior Scientist, Cell & Gene Therapy Development – Safety and efficacy testing for CAR-T trials and oncolytic viruses.

Read more

Event website

Date: 16-18 October 2024
Location: Washington, DC, USA

Presenting:
Martin Roberge, Associate Director R&D

Event Website

Date: 4-8 October 2024
Location: Seatlle, Washington, USA

Presenting:

1. Process Improvement in Clinical Sample Testing with Quality Checks and Efficient Workflow for Global Clinical trials.
Manpreet Singh, et al.

2. Optimization, Validation and Implementation of a 25-color Flow Cytometry Assay on Cytek® Aurora Instrument to Monitor Immune Cells in Whole Blood for Multi-Location Clinical Trials.
Shawn Mehrzad, , et al.

3. Development and global validation of a clinical flow cytometry testing protocol for assessing functional T cell responses using intracellular cytokine staining.
Christopher Rota, , et al.

Event Website

Date: 14-17 September 2024
Location: Barcelona, Spain

Presenting: Xavier Pichon, Principal Scientist – Analytic Validation of Biomarkers, joint poster presentation with AI Foria

Event Website

We are happy to announce that Cerba Research will attend the World Vaccine Congress 2024 from April 1st – 4th in Washington, USA.  Meet the Cerba Research team and discover how we are setting the standards to protect the world against infectious diseases.

The implementation of the new In Vitro Diagnostic Regulation (IVDR) within the European Union (EU) has introduced profound changes with far-reaching impacts on both manufacturers and users of in vitro diagnostic devices.

Join this X-Talks webinar to learn how the new In Vitro Diagnostic Regulation (IVDR) impacts manufacturers and users of diagnostic devices.

The Cerba Research team will be attending the Outsourcing in Clinical Trials East Asia conference on 5th & 6th November in Seoul, South Korea. Over a span of two days, our experts will be revealing how Cerba Research is transforming research and advancing health!

The Cerba Research team will be attending the 15^th Outsourcing in Clinical Trials New England conference on 1 & 2 November in Boston. Over a span of two days, our experts will be revealing how to have an agile approach to  PBMC collection in vaccine trials. 

The Cerba Research team will be attending ESMO 2023 in Madrid! Meet our scientists Renaud Burrer, Xavier Pichon, Rania Gaspo and discover our poster on Artificial Intelligence and its application to the analysis of solid tumors.

We are happy to announce that Cerba Research will attend the World Vaccine Congress 2023 from October 16 – 19 in Barcelona Spain. Meet the Cerba Research team and discover how we are setting the standards to protect the world against infectious diseases.

The Cerba Research team will be attending the 11^th Outsourcing in Clinical Trials Southern California on 26 & 27 September in La Jolla, California. Over a span of two days, our experts Chizoba Okoro and Matthew Jones will be revealing how Cerba Research is transforming research and advancing health!

The Cerba Research team will attend the 38^th International Clinical Cytometry Meeting & Course (ICCS2023) in New Orleans! We will be sharing how Cerba Research is transforming the field of clinical flow cytometry with advanced methods and cutting-edge technologies in various poster presentations!

The Cerba Research team will be attending ESSCA 2023 in Utrecht! Meet our scientists Amber Baele, Feyzâ Matisli, Eva Van Lombergen, and Silke De Waele, and discover the various posters they will present there.

Complex flow cytometry is critical for today’s personalized medicine. With the breakthrough of cellular immune therapies, such as CAR+ T, flow cytometry became a critical platform for clinical laboratories, drug developers, and manufacturers.

Meet the Cerba Research Team at the Disease Prevention & Control Summit. An increasingly integrated world has heightened the need for expertise in identification and surveillance of infectious diseases allowing for decisive, agile and dynamic response to rising threats. Understanding viruses and the immune response on a global scale will drive (non) clinical studies forward to meet these threats.

Discover how Cerba Research is setting the standards to protect the world against infectious diseases!

Cerba Research is proud to participate in the esteemed 8th CAR TCR Summit, bringing together the sector’s experts in the field of Adoptive Cell Therapy. As a leading player in clinical research, Cerba Research is excited to showcase our specialty solutions and biomarker services in the field of CAR+T.

Our heritage in specialty labs combined with our experience in central lab services enables us to develop research techniques that will underpin the next generation of clinical trials. A new kind of research where diagnostics are driven by clinical trial data, and insights, supported by specific therapeutic expertise.

Meet Cerba Research at Bio Asia Taiwan 2023! BIO Asia–Taiwan 2023 Onsite + Online will take place from July 26-30 in Taipei, Taiwan. It aims to bring together biotech and pharmaceutical executives and investors from around the world to explore business opportunities and engage with Taiwan’s emerging biotech sector. The five-day event includes a three-day conference, company presentations, partnering meetings, symposia, workshops, and an international exhibition.

This year’s theme, “Embracing Asian Dynamics,” highlights the opportunities in Asia’s fast-moving economies and innovative biomedical ecosystems, with Taiwan serving as the host country known for its successful response to COVID-19 and strong innovation.

Meet our IVD experts at AACC 2023 and discover how we can help you transform research and advance health! We are enabled by leading diagnostic and healthcare infrastructure, demographically rich data and industry-leading laboratories with over 1,000 pathology experts in major therapeutic areas power our services dedicated to IVD development.

This way we can support your product’s IVDR or FDA compliance, design and manage a clinical trial, perform a large-scale testing project, or even a biospecimen collection.

CHI’s 7th Annual Immuno-Oncology Summit Europe returns to London’s Canary Wharf for three packed days of science and technology discussions on the recent advances in the development of promising immuno-oncology therapies.

The Summit, scheduled for 20-22 June 2023, comprises 4 conference programs, from strategies on Modulating the Tumour Microenvironment; to various treatment modalities including Next-Generation Cell-Based Immunotherapies; Bispecific and Multi-Specific Antibody Therapeutics, and Gamma Delta Immunotherapy.

The European Association for the Study of the Liver (EASL) Annual Congress is a major international conference for researchers, physicians, and other healthcare professionals in the field of liver disease.

The EASL congress brings together researchers, clinicians, and other healthcare professionals to present and discuss the latest advances in liver disease research and treatment. The conference will cover a wide range of topics related to liver disease, including viral hepatitis, metabolic liver disease, liver cancer, and more. It also includes keynote lectures, symposia, and workshops on cutting-edge research and clinical practice in hepatology.

The EHA2023 Hybrid Congress offers you an interactive, comprehensive program dedicated to clinical research and practice, basic and translational research, as well as important opportunities for collaboration with stakeholders in the field of hematology.

The educational and scientific program will highlight state-of-the-art clinical practice, the latest findings in hematology research, and recent approaches on the diagnosis and treatment of hematologic diseases.

Join Cerba Research and other fellow oncology professionals at the 2023 ASCO Annual Meeting – a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care.

The 2023 ASCO Annual Meeting is your all-access pass to join global cancer experts and discover the latest innovations in cancer research and education. This year’s program will feature over 200 sessions complementing Dr. Eric Winer’s Presidential theme Partnering With Patients: The Cornerstone of Cancer Care and Research.

Discover effective strategies for outsourcing clinical trial operations to ensure trials run smoothly and within budget at OCT East Coast 2023. Join us for a two day event filled with case studies, panel discussion and face to face networking opportunities around clinical operations, technology and innovation, and data management.

Connect with us and discover how Cerba Research offers world-class clinical research that helps life science companies to successfully develop the predictive and precision medicines of the future.

CYTO 2023, the Congress for the International Society for the Advancement of Cytometry will be a premier, inclusive, and international conference on the many facets of cytometry science and engineering.

Meet the Cerba Research flow cytometry team and discover how Cerba Research is committed to validating your assay with standardized instruments across labs, by applying independent quality control steps to monitor instrument performance.

The ASGCT Annual Meeting will be the world’s largest gathering of gene and cell therapy researchers and provides an international forum where the latest scientific developments are presented and critically discussed. Meet the Cerba Research Team and discover how we are transforming research and advancing health with Cell & Gene therapy!

Meet us at booth 849

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine.

From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world. Discover how we can transform your research and advance health!

Meet us at booth 3148

Discover more

The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain.

If you are involved in vaccines or new to it because of the pandemic, this is the most important meeting you will be part of. Uniting vaccine experts – sharing groundbreaking knowledge – tackling the pandemic.

Meet us at Booth 219

For more than 10 years, the AFCROs (French Association of CROs) has been organizing La 11ème Journée de la Recherche Clinique (Clinical Research Day), which brings together more than 400 participants from industry, academia, physicians, patient associations, CROs, research departments and clinical research service providers.

This day is organized around workshops on topics such as: the European Medicines Regulation, dematerialization of clinical trials, e-learning tools to accelerate patient involvement in research and many other topics that are key to our patient-centered clinical trial offerings.

Download our resource pack here

For the 15th Annual event, this flagship show will focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed.

Meet up with our experts Chelsea Riveley Madison Bishop & Leen-Jan van Doorn and discover how we can help you transform research and advance health!

As the physical world has returned to normal and everyone is excited to network in person, join us in London this February with those trailblazing the next wave of CAR and TCR based approaches across next-generation platform design, clinical development, and manufacturing processes.

Take advantage of cutting-edge innovation from global biopharma leaders in cell armouring, combination approaches and multiplexing gene engineering to improve cell durability and trafficking across allogeneic and solid tumour indications, and leave understanding the technical strategies to build automated, closed-system manufacturing processes to ensure vein to vein time is less than a week.

Want to know more about our capabilities? Download our Resource Pack here